“Archangels gave me my life back. Their team is the most amazing, caring people I have ever met. The housing they sent me to was amazing, the groups are amazing, and this whole project is amazing. If you're tired of being sick and tired, reach out and save your life.”
“This facility is run by some of the best people you could ever ask for. They are extremely professional and truly dedicated to helping those struggling with mental health and addiction. They truly saved my life. I will be forever grateful for everything they did for me.”
“I had the honor of touring this facility, and it was absolutely beautiful, clean, and thoughtfully designed. But more than how it looked, you could feel the love in every detail. Watching the staff interact with clients genuinely touched my heart.”
Plain, fact-first answers about how care works here. Want to talk to a person? Call (888) 464-2144.
A 60-second walkthrough of the Tinton Falls clinic, the space where the program actually runs.
Methamphetamine is a potent synthetic stimulant with a long history of medical use (for ADHD, narcolepsy, and obesity in tightly controlled formulations) and a much larger history of illicit use. The current illicit supply is dominated by high-purity, low-cost methamphetamine produced largely outside the United States. Use disorders have risen sharply in the past decade, often in patterns of overlap with opioid use, and meth-involved overdose deaths now include a meaningful share involving fentanyl contamination. This page covers methamphetamine pharmacology, the specific medical and psychiatric risks, the withdrawal pattern, and evidence-based treatment.
There are currently no FDA-approved medications specifically for methamphetamine use disorder. Treatment evidence concentrates on structured behavioral approaches and treatment of co-occurring conditions.
Methamphetamine is a sympathomimetic stimulant chemically related to amphetamine but more potent and longer-acting. It releases dopamine, norepinephrine, and serotonin into the synapse and blocks their reuptake, producing prolonged stimulant effect. The illicit form is most commonly the smokable or injectable "crystal meth" (d-methamphetamine hydrochloride).
Routes of use include smoking (most common in current U.S. patterns), injection, snorting, and oral use. Effects last 6 to 12 hours, much longer than cocaine, which drives a different binge pattern.
Two facts shape the current clinical picture:
1. High purity, low cost. The illicit supply over the past decade has shifted from small-scale domestic production to large-scale production by international networks, with much higher potency at much lower prices than historical street meth. 2. Fentanyl contamination is real. Although less prevalent than in heroin, fentanyl contamination of methamphetamine has been documented in many U.S. markets. Carry naloxone.
These shifts are why the medical profile of meth use disorder today is more severe than it was twenty years ago.
Group rooms, private therapy offices, the medical office, family programming rooms, and the wellness space, designed for clinical depth and nervous-system regulation.
Methamphetamine withdrawal is primarily psychological, but the depression and exhaustion can be severe. The typical pattern:
Suicidality in the post-crash window is a real clinical concern. Treatment in this phase often includes close monitoring and (where indicated) inpatient stabilization. The Archangel Centers does not provide inpatient or detox on-site; we coordinate placement with accredited partner facilities when needed.
Diagnosis follows the DSM-5 substance use disorder framework applied to amphetamine-type stimulants, with at least two of eleven criteria within twelve months. Common patterns:
Treatment integrates cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing, narrative therapy, and trauma-informed care with EMDR available in individual therapy. The medical provider manages MAT (Suboxone, Vivitrol, Sublocade) and psychiatric medications when indicated.
Intake uses the full evidence-based battery: ASAM Criteria, LOCUS for mental health acuity, PHQ-9, GAD-7, the Columbia Suicide Severity Rating Scale, plus biopsychosocial, nutrition, and pain screens. The assessment drives the treatment plan from day one.
See Our ModalitiesNo FDA-approved medications exist for methamphetamine use disorder. Treatment concentrates in the following.
Methamphetamine use disorder is heavily comorbid with depression, ADHD, anxiety, and trauma-related disorders. Treating the underlying conditions reduces use. See depression and addiction, ADHD and addiction, and PTSD and addiction.
Several medications have shown signal in trials for stimulant use disorder, though none are currently FDA-approved for this indication. Clinical decisions about off-label use are made by the medical provider on a case-by-case basis.
For clients in active psychosis or with severe medical complications, coordinated inpatient placement is often the right starting point.
Polysubstance use of methamphetamine and opioids is increasingly common. When both are present, the treatment plan addresses both, with MAT for the opioid component (Suboxone, Sublocade, or Vivitrol; methadone is not in our formulary). See polysubstance use.
“I came back from rock bottom. I'm here because I want to show others they can too. This isn't just a business. It's my mission.”- Mike Sorrentino, Founder
Mike and Lauren Sorrentino did not set out to build a generic treatment center. They wanted a recovery-grounded program that mixes lived experience, licensed clinical expertise, and family programming that actually moves the needle for the people who love someone in active addiction.
The clinic that resulted is small enough that each client knows their primary therapist by name, but resourced enough to deliver the full ASAM continuum from Partial Care through outpatient continuing care, with MAT and EMDR available when clinically indicated.
Read the Full StoryMost clients leave the first admissions call with a clinical assessment, an insurance verification, and a scheduled start date. Recovery starts with a decision, not a commitment. The admissions line is staffed around the clock.
Confidential, 24/7 admissions. Same-week placement is often available. Verify your insurance free of charge before any commitment.
(888) 464-2144Verify Your Insurance
